India covid-19 vaccine India

Shilpa Medicare to make Cadila's ZyCoV-D Covid vaccine

Reading now: 131
www.livemint.com

three-dose Covid-19 vaccine ZyCoV-D, the company said in a statement on Friday. As per a regulatory filing, the Shilpa Medicare has “entered into a definitive agreement with Cadila Healthcare Ltd (CHL) for production-supply of the ZyCov-D vaccine drug substance from its integrated Biologics R&D cum Manufacturing center at Dharwad, Karnataka." The targeted production of the ZyCoV-D vaccine from this facility will be mutually agreed upon by both parties, it added. "The company will transfer the ZyCoV-D technology to Shilpa Biologicals Pvt Ltd (SBPL).

Under the agreement, SBPL will be responsible for the  manufacture of the drug substance of the vaccine, while the company is responsible for filling/packaging /distribution /marketing of the

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA